Cargando…
Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Japan Atherosclerosis Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803830/ https://www.ncbi.nlm.nih.gov/pubmed/32863291 http://dx.doi.org/10.5551/jat.CR004 |
| _version_ | 1783636029638443008 |
|---|---|
| author | Yamashita, Shizuya Masuda, Daisaku Akishita, Masahiro Arai, Hidenori Asada, Yujiro Dobashi, Kazushige Egashira, Kensuke Harada-Shiba, Mariko Hirata, Kenichi Ishibashi, Shun Kajinami, Kouji Kinoshita, Makoto Kozaki, Koichi Kuzuya, Masafumi Ogura, Masatsune Okamura, Tomonori Sato, Kayoko Shimano, Hitoshi Tsukamoto, Kazuhisa Yokode, Masayuki Yokote, Koutaro Yoshida, Masayuki |
| author_facet | Yamashita, Shizuya Masuda, Daisaku Akishita, Masahiro Arai, Hidenori Asada, Yujiro Dobashi, Kazushige Egashira, Kensuke Harada-Shiba, Mariko Hirata, Kenichi Ishibashi, Shun Kajinami, Kouji Kinoshita, Makoto Kozaki, Koichi Kuzuya, Masafumi Ogura, Masatsune Okamura, Tomonori Sato, Kayoko Shimano, Hitoshi Tsukamoto, Kazuhisa Yokode, Masayuki Yokote, Koutaro Yoshida, Masayuki |
| author_sort | Yamashita, Shizuya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7803830 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Japan Atherosclerosis Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78038302021-01-27 Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia Yamashita, Shizuya Masuda, Daisaku Akishita, Masahiro Arai, Hidenori Asada, Yujiro Dobashi, Kazushige Egashira, Kensuke Harada-Shiba, Mariko Hirata, Kenichi Ishibashi, Shun Kajinami, Kouji Kinoshita, Makoto Kozaki, Koichi Kuzuya, Masafumi Ogura, Masatsune Okamura, Tomonori Sato, Kayoko Shimano, Hitoshi Tsukamoto, Kazuhisa Yokode, Masayuki Yokote, Koutaro Yoshida, Masayuki J Atheroscler Thromb Correspondence Japan Atherosclerosis Society 2020-11-01 /pmc/articles/PMC7803830/ /pubmed/32863291 http://dx.doi.org/10.5551/jat.CR004 Text en 2020 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Correspondence Yamashita, Shizuya Masuda, Daisaku Akishita, Masahiro Arai, Hidenori Asada, Yujiro Dobashi, Kazushige Egashira, Kensuke Harada-Shiba, Mariko Hirata, Kenichi Ishibashi, Shun Kajinami, Kouji Kinoshita, Makoto Kozaki, Koichi Kuzuya, Masafumi Ogura, Masatsune Okamura, Tomonori Sato, Kayoko Shimano, Hitoshi Tsukamoto, Kazuhisa Yokode, Masayuki Yokote, Koutaro Yoshida, Masayuki Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia |
| title | Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia |
| title_full | Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia |
| title_fullStr | Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia |
| title_full_unstemmed | Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia |
| title_short | Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia |
| title_sort | guidelines on the clinical evaluation of medicinal products for treatment of dyslipidemia |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803830/ https://www.ncbi.nlm.nih.gov/pubmed/32863291 http://dx.doi.org/10.5551/jat.CR004 |
| work_keys_str_mv | AT yamashitashizuya guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT masudadaisaku guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT akishitamasahiro guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT araihidenori guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT asadayujiro guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT dobashikazushige guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT egashirakensuke guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT haradashibamariko guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT hiratakenichi guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT ishibashishun guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT kajinamikouji guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT kinoshitamakoto guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT kozakikoichi guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT kuzuyamasafumi guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT oguramasatsune guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT okamuratomonori guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT satokayoko guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT shimanohitoshi guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT tsukamotokazuhisa guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT yokodemasayuki guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT yokotekoutaro guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia AT yoshidamasayuki guidelinesontheclinicalevaluationofmedicinalproductsfortreatmentofdyslipidemia |